The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Pfizer, Apple, Pulte, Synaptics, Perkinelmer

Fri, 26th Apr 2013 12:16

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t)

April 26 (Reuters) - Some U.S. stocks to watch on Friday:

FUTURES LOWER WITH GDP DATA, EARNINGS ON TAP

Index futures dipped, indicating the S&P 500 may snap afive-day winning streak ahead of data on economic growth andconsumer sentiment. S&P 500 futures were down 5.9 points.Dow Jones industrial average futures lost 46 points, andNasdaq 100 futures declined 11 points.

** PFIZER INC, Thursday close $30.26, down 3 pctpremarket

European regulators declined to approve marketing ofPfizer's new rheumatoid arthritis treatment Xeljanz, citing therisks of the drug compared with its potential benefit, thecompany said on Thursday.

** APPLE INC, Thursday close $408.38, down 0.3 pctpremarket

Samsung Electronics Co Ltd grabbed moresmartphone market share from arch rival Apple in the latestquarter, with sales of its phones jumping to account for onethird of the global market, research firm IDC said.

** CHEVRON CORP, Thursday close $118.51

The second-largest U.S. oil company reports first-quarterresults before market opens on Friday which are expected to showa dip in profit after production declined from a relativelystrong fourth quarter.

** TYCO INTERNATIONAL LTD, Thursday close $31.08

The fire safety and security systems maker reported a 45percent fall in quarterly profit as it took a $124 millioncharge, almost half of which was related to an environmentalissue at a plant in Wisconsin.

** ABBVIE INC, Thursday close $44.24

AbbVie, the pharmaceuticals business spun off in January byAbbott Laboratories, reported slightly better thanexpected quarterly results, fueled by surging sales of itsHumira treatment for rheumatoid arthritis.

** WEYERHAEUSER CO, Thursday close $31.38, up 1.8 pctpremarket

The forest products company reported a first-quarter netprofit that more than tripled due to a recovery in the U.S.housing market, and said it expects higher volumes for all itswood products for the current quarter.

** VF Corp, Thursday close $178.75, up 2 pctpremarket

The company, known for its flagship clothing brands TheNorth Face and The Vans, reported a 26 percent increase infirst-quarter profit, helped by better margins.

** THERAVANCE, Thursday close $30.92, up 5 pct premarket

The company plans to split into two publicly traded U.S.companies, separating some of its most advanced respiratorydrugs under development with GlaxoSmithKline Plc fromits other biopharmaceutical operations.

** USG CORP, Thursday close $26.20, down 1 pctpremarket

RBC Capital Markets cut its rating on the building productsmaker's stock to "outperform" from "top pick," and said thoughit continues to have a favorable view of the company'shigh-margin ceiling grid business, demand would remain choppy.

** D.R. HORTON INC, Thursday close $24.53, up 6 pctpremarket

** LENNAR CORP, Thursday close $41.93, up 3 pctpremarket

The No.1 U.S. home builder reported a 173 percent jump inquarterly profit and said the spring selling season was off to astrong start. Record-low interest rates and rising rents haveprompted Americans to buy homes, leading to shortage of newhouses.

Homebuilder Lennar's stock was also up on the news.

** CIRRUS LOGIC INC, Thursday close $19.62, down 3pct premarket

The audio chipmaker on Thursday reported fourth-quarterresults above analysts' expectations, but brokerage Needham &Company cut its target price on the company's stock, citinglower revenue from Apple than "previously anticipated."

** PULTEGROUP INC, Thursday close $20.79, up 1.3 pctpremarket

The No. 2 U.S. homebuilder reported a better-than-expectedquarterly profit on Thursday as its strategy of selling fewerhomes at higher prices paid off. [ID;nL3N0DC8SL]

** SIMON PROPERTY GROUP, Thursday close $176.01

The biggest U.S. owner of malls and outlet centers saidfunds from operations, a key earnings measure, rose in the firstquarter, helped by higher occupancy, rents and sales at itsmalls and outlet centers, and beat estimates.

** LAZARD LTD, Thursday close $33.16

The investment bank reported a 40 percent fall infirst-quarter profit, earning less from its financial advisorybusiness in a subdued merger and acquisitions market.

** TRANSCANADA CORP , Thursday close $48.74

Canada's largest pipeline company reports first-quarterearnings as the company awaits U.S. approvals for itscontroversial Keystone XL project. It should update its progressin building Keystone XL's southern link from Cushing, Oklahoma,to Nederland, Texas, and how much interest its planned eastcoast pipeline is receiving from oil producers.

** AMAZON.COM INC, Thursday close $274.70, down 2.8pct premarket

Revenue growth slowed in the first quarter as the world'slargest Internet retailer struggled overseas, but margins jumpedon lower shipping expenses and the expansion of more profitablenew businesses.

** STARBUCKS CORP, Thursday close $60.50, down 2pct premarket

It reported higher quarterly profit on Thursday that matchedWall Street estimates and it raised its full-year earningsforecast. But revenue was slightly below analysts' estimates.

** BAIDU INC, Thursday close $92.34, down 9 pctpremarket

China's largest search engine will increase marketingexpenditures for the rest of the year to counter competitionfrom rival Qihoo 360 Technology, which may further putthe brakes on profit growth.

** COINSTAR INC, Thursday close $55.03, up 8.3 pctpremarket

Coinstar raised its full-year adjusted profit forecast ONThursday as it bets on a slate of movies scheduled to bereleased in the third quarter to boost its Redbox video rentalbusiness.

** PERKINELMER INC, Thursday close $34.47, down 10.3pct premarket

The maker of scientific instruments, diagnostic equipmentand environmental safety monitoring products on Thursdayreported lower-than-expected first-quarter profit and decreasedits full-year forecast as difficult economic conditions and astronger dollar hurt sales in Europe and Japan.

** ECHO GLOBAL LOGISTICS INC, Thursday close$19.08, down 5 pct premarket

The logistics company cut its 2013 earnings forecast tobetween 78 and 84 cents per share from between 82 and 90 cents,and lowered its revenue outlook to $900 million to $940 millionfrom $940 million to $980 million.

Analysts on average were expecting earnings of 85 cents pershare on revenue of $960.6 million, according to Thomson ReutersI/B/E/S.

** J.C. PENNEY CO, Thursday close $15.24, up 8 pctpremarket

Billionaire investor George Soros reported a 7.9 percentpassive stake in the struggling department store chain onThursday.

** FREESCALE SEMICONDUCTOR LTD, Thursday close$14.55, up 8 pct after market

The chipmaker reported a much smaller-than-expectedfirst-quarter loss and forecast upbeat second-quarter revenue,as demand from its Chinese customers improved.

** EXPEDIA INC, Thursday close $64.97, down 7.6 pctafter market

The online travel agency reported a higher-than-expectedfirst-quarter adjusted profit, but warned of a lower full-yearprofit from its discount travel website Hotwire due to highercar rental rates and increased competition.

** MICROS SYSTEMS INC, Thursday close $43.52, down6.5 pct after market

The company, which makes data management systems forretailers and hotel chains, reported much weaker-than-expectedthird-quarter results, as hardware sales grew a lacklustre 2percent and software sales declined. Micros also cut itsfull-year outlook.

** VERISIGN INC, Thursday close $46.10, up 3 pctafter market

The issue of .com and .net Internet domains names reported abetter-than expected quarterly profit as revenue rose 15percent. Excluding items, the company earned 58 cents per share,on revenue of $236 million. Analysts expected an adjusted profitof 54 cents per share and revenue of 232.6 million, according toThomson Reuters I/B/E/S.

** INTERNATIONAL GAME TECHNOLOGY, Thursday close$17.30, up 1 pct after market

The slot-games maker on Thursday reportedbetter-than-expected second-quarter results on higher revenuefrom its social gaming business, which more than doubled from ayear earlier. The company, whose stock touched a year-highyesterday, also raised its full-year 2013 forecast for adjustedprofit, prompting J.P. Morgan and another brokerage to raisetheir target price on the company's stock.

** ALTERA CORP, Thursday close $32.93, down 2.2 pctafter market

The programmable chipmaker posted revenue slightly belowexpectations in the first quarter and said it was beginning tosee a recovery from a dip in demand from its communications andindustrial customers.

** SYNAPTICS INC, Thursday close $38.54, up 19.4pct premarket

The touchscreen chipmaker forecast current-quarter resultsfar above analysts' estimates on Thursday and confirmed that ithad won contracts from Samsung Electronics Co Ltd for its Galaxy S4 smartphone and Note 8 tablet.

** LOGMEIN INC, Thursday close $17.86, up 17 pctafter market

The maker of remote-access software postedbetter-than-expected quarterly results as it won a record 37,000paying subscribers, and the company forecast second-quarterrevenue above analysts' estimates.

** INFORMATICA CORP, Thursday close $32.31, up 9pct after market

** QLIK TECHNOLOGIES INC, Thursday close $23.85, up14 pct after market

The business software makers reported better-than-expectedquarterly revenue and raised their full-year revenue forecastsas enterprises spent more on integrating and analyzing data.

** KLA-TENCOR CORP, Thursday close $55.90, down 5pct after market

The chip equipment maker reported lower quarterly results onThursday and said its outlook for the rest of the year hasweakened due to manufacturers' concerns about the globaleconomy.

** HOMEX DEVELOPMENT CORP , Thursday close$7.02, down 11 pct after market

The Mexican homebuilder's first-quarter profit and revenuefell sharply as it struggled with slowing home sales and arising debt load, the company said on Thursday.

** H&R BLOCK INC, Thursday close $28.03, down 4 pctafter market

The tax preparer said its share of tax returns prepared sofar this year has remained essentially flat, compared with ayear earlier, sending its stock down 9 percent after the bell.

** MOLINA HEALTHCARE INC, Thursday close $33.23, up3 pct in after-hours trade

The health insurer reported a first-quarter profit that wasmuch above analysts' estimates, helped by a rate increase as itsCalifornia health plan and better performance at the Florida,Texas, Ohio and Wisconsin health plans, among others.

** DECKERS OUTDOOR CORP, Thursday close $59.4, down2 pct after market

The shoe maker, known for its UGG boots, on Thursdayforecast a current quarter loss of about $1.10 per share.Analysts on average were expecting a loss of 96 cents per share,according to Thomson Reuters I/B/E/S.

Both Canaccord Genuity and ISI Group said investors weredisappointed with the unexpected increase in first-quarterinventories and the second-quarter guidance. (Compiled by Sruthi Ramakrishnan in Bangalore; Editing byJoyjeet Das)

More News
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.